Advantages of array-based technologies for pre-emptive pharmacogenomics testing

- Shahandeh, Al, Johnstone, Daniel M., Atkins, Joshua R., Sontag, Jean-Marie, Heidari, Moones, Daneshi, Nilofar, Freeman-Acquah, Elvis, Milward, Elizabeth A.

Gene-microRNA interactions associated with antipsychotic mechanisms and the metabolic side effects of olanzapine

- Santarelli, Danielle M., Liu, Bing, Duncan, Carlotta E., Beveridge, Natalie J., Tooney, Paul A., Schofield, Peter R., Cairns, Murray J.

Issues of pharmacogenomics in monitoring warfarin therapy

- Martin, Jennifer, Somogyi, Andrew

Personalised medicine: a new approach to improving health in Indigenous Australian populations

- Rae, Kym M., Grimson, Steve, Pringle, Kristy G.

Potential simple and multifactorial drug-gene interactions of tricyclic antidepressants in older Australians

- Biswas, Mohitosh, Dias, Thilani H., Daneshi, Nilofar, Holliday, Elizabeth, Hancock, Stephen, Attia, John, Scott, Rodney, Newby, David, Kerr, Karen P., Milward, Elizabeth A.

Precision medicine: drowning in a regulatory soup?

- Nicol, Dianne, Bubela, Tania, Otlowski, Margaret, Ries, Nola M., Skene, Loane, Stewart, Cameron, Wagner, Jennifer, Zeps, Nik, Chalmers, Don, Charbonneau, Jan, Critchley, Christine, Dickinson, Joanne, Fleming, Jennifer, Hewitt, Alex W., Liddicoat, Johnathan, McWhirter, Rebekah

Preliminary analysis of potential drug and gene interactions involving tricyclic antidepressant drugs

- Biswas, Mohitosh, Dias, Thilani H., Daneshi, Nilofar, Holliday, Elizabeth, Hancock, Stephen, Attia, John, Scott, Rodney, Newby, David, Kerr, Karen P., Milward, Elizabeth A.

Prevalence of clinically actionable genotypes and medication exposure of older adults in the community

- Daneshi, Nilofar, Holliday, Elizabeth, Hancock, Stephen, Schneider, Jennifer J., Scott, Rodney J., Attia, John, Milward, Elizabeth A.